Adolore Biotherapeutics, Inc.
CIK 1904161 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adolore Biotherapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 29, 2025 | D | 0001904161-25-000002 |
| Jan 25, 2024 | D | 0001904161-24-000001 |
| Jan 13, 2022 | D | 0001904161-22-000001 |